Author

Fangzhou Lin

Fujian Medical UniversityPrimary ORCID profile (0000-0002-1749-3599 · 2 papers)Unclaimed ORCID profile · follow to get notified of new preprints

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

Fangzhou LiniD2 papers · Tohoku University

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:mouse· 1 Assay:proteomics· 1

Frequent Co-Authors

Haijun YuiD· 1 shared Honghao YeiD· 1 shared Huan YangiD· 1 shared Luobin Guo· 1 shared Ruijing TangiD· 1 shared Tingting CheniD· 1 shared Tingyu Wei· 1 shared Xiaolong LiuiD· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Haijun YuORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Engineering PEG10 assembled endogenous virus-like particles with genetically encoded neoantigen peptides for cancer vaccination

Ruijing Tang, Luobin Guo, Tingyu Wei, Tingting Chen, Huan Yang, Honghao Ye, Fangzhou Lin, Yongyi Zeng, Haijun Yu, Zhixiong Cai, Xiaolong Liu

This paper develops ePAC, a cancer vaccine using PEG10-based virus-like particles to deliver neoantigens and adjuvants, showing efficacy in preclinical models.

eLife · Jun 20, 2024Peer-reviewedCancer Biology